Re-evaluation of PRRT2 mutations in paroxysmal disorders

Area of Science:

• Genetics
• Neurology
• Molecular Biology

Background:

• Mutations in the proline-rich transmembrane protein 2 (PRRT2) gene are recognized as a primary cause of several neurological disorders.
• These include benign familial infantile epilepsy (BFIE), infantile convulsions with choreoathetosis syndrome (ICCA), and paroxysmal kinesigenic dyskinesia (PKD).
• Previous studies have suggested associations between PRRT2 mutations and other paroxysmal conditions, such as febrile seizures and migraines.

Purpose of the Study:

• To re-evaluate the genetic and clinical correlations of PRRT2 mutations in patients presenting with PKD/ICCA and other paroxysmal disorders.
• To clarify the spectrum of phenotypes associated with PRRT2 gene mutations.
• To identify novel mutations within the PRRT2 gene.

Main Methods:

• Genetic analysis of PRRT2 in patients diagnosed with PKD/ICCA and other paroxysmal neurological conditions.
• Clinical evaluation and correlation of identified mutations with patient phenotypes.
• Sequencing of the PRRT2 gene to detect mutations.

Main Results:

• Two novel mutations in the PRRT2 gene were identified in patients with PKD/ICCA.
• No PRRT2 mutations were detected in patients with other investigated paroxysmal disorders.
• This suggests a more specific genotype-phenotype correlation than previously assumed.

Conclusions:

• Benign familial infantile epilepsy (BFIE) and paroxysmal kinesigenic dyskinesia (PKD) remain the core phenotypes associated with PRRT2 mutations.
• The findings narrow the spectrum of PRRT2-related disorders, emphasizing its role in specific epilepsy and dyskinesia syndromes.
• Further research may be needed to explore the genetic basis of other paroxysmal disorders previously linked to PRRT2.